Other Investments Ideas

Inventiva

9.30  -0.19  -2 
IVA
Financial Report
1st of August 2022
NASDAQ
IVA

Immunoprecise Antibodies

4.61  -0.3  -6.11 
IPA
NASDAQ
IPA

Inmed Pharmaceuticals

0.77  -0.02  -2.53 
INM
Fiscal Year End
23rd of September 2022
NASDAQ
INM
NASDAQ
BIIB

Inhibikase Therapeutics

0.66  0.03  4.76 
IKT
Fiscal Quarter End
31st of December 2021
NASDAQ
IKT

Fusion Pharmaceuticals

3.87  -0.11  -2.76 
FUSN
Last Financial Announcement
31st of December 2020
NASDAQ
FUSN

Premier Biomedical

0.0015  -0.0001  -6.25 
BIEI
OTC
BIEI

Fulcrum Therapeutics

8.51  -0.13  -1.5 
FULC
Last Financial Announcement
31st of December 2020
NASDAQ
FULC

Biohaven Pharmaceutical

142.03  0.98  0.69 
BHVN
Last Financial Announcement
31st of December 2020
NYSE
BHVN

Denali Therapeutics

24.72  0.95  4.00 
DNLI
Last Financial Announcement
31st of December 2020
NASDAQ
DNLI

Hutchmed China

9.58  0.39  4.24 
HCM
Last Financial Announcement
31st of December 2020
NASDAQ
HCM

Horizon Therapeutics

90.35  1.01  1.13 
HZNP
Last Financial Announcement
31st of December 2020
NASDAQ
HZNP

MeiraGTx Holdings

8.71  0.62  7.66 
MGTX
Last Financial Announcement
31st of December 2020
NASDAQ
MGTX

Magenta Therapeutics

1.22  -0.24  -16.44 
MGTA
Last Financial Announcement
31st of December 2020
NASDAQ
MGTA

Kala Pharmaceuticals

0.65  -0.03  -4.41 
KALA
Last Financial Announcement
31st of December 2020
NASDAQ
KALA

Kalvista Pharmaceuticals

9.02  -0.18  -1.96 
KALV
Financial Report
12th of July 2022
NASDAQ
KALV

Glaxosmithkline Plc

44.52  0.96  2.20 
GSK
Last Financial Announcement
31st of December 2020
NYSE
GSK

Macrogenics

3.98  0.08  2.05 
MGNX
Last Financial Announcement
31st of December 2020
NASDAQ
MGNX

F-Star Therapeutics

2.53  -0.03  -1.17 
FSTX
Last Financial Announcement
31st of December 2020
NASDAQ
FSTX

Global Blood

27.33  0.49  1.83 
GBT
Last Financial Announcement
31st of December 2020
NASDAQ
GBT

Diamedica Therapeutics

2.38  -0.04  -1.65 
DMAC
Last Financial Announcement
31st of December 2020
NASDAQ
DMAC

Intellipharmaceutics

0.11  -0.01  -8.33 
INT
Fiscal Quarter End
30th of November 2021
OTC
IPCIF

Forward Pharma

5.55  0.31  5.92 
FWP
Fiscal Quarter End
31st of December 2021
NASDAQ
FWP

Haymaker Acquisition

10.00  0.22  2.25 
HYAC
NASDAQ
HYAC

Freeline Therapeutics

0.74  -0.02  -2.63 
FRLN
Last Financial Announcement
31st of December 2020
NASDAQ
FRLN

Frequency Therapeutics

1.11  -0.16  -12.6 
FREQ
Last Financial Announcement
31st of December 2020
NASDAQ
FREQ

Mesoblast

3.51  -0.07  -1.96 
MESO
Financial Report
1st of June 2022
NASDAQ
MESO

Mei Pharma

0.49  0.02  4.26 
MEIP
Fiscal Year End
1st of September 2022
NASDAQ
MEIP

Beam Therapeutics

35.19  1.25  3.68 
BEAM
Last Financial Announcement
31st of December 2020
NASDAQ
BEAM

Emergent Biosolutions

35.33  3.64  11.49 
EBS
Last Financial Announcement
31st of December 2020
NYSE
EBS

Medavail Hldg

1.69  0.02  1.20 
MDVL
Last Financial Announcement
31st of December 2020
NASDAQ
MDVL
NASDAQ
MDWD

Black Diamond

1.71  -0.07  -3.93 
BDTX
Last Financial Announcement
31st of December 2020
NASDAQ
BDTX

Dyne Therapeutics

5.51  0.08  1.47 
DYN
Last Financial Announcement
31st of December 2020
NASDAQ
DYN

Medicenna Therapeutics

0.96  -0.06  -5.88 
MDNA
Financial Report
27th of May 2022
NASDAQ
MDNA

Equillium

2.50  -0.03  -1.19 
EQ
Last Financial Announcement
31st of December 2020
NASDAQ
EQ

Madrigal Pharmaceuticals

66.71  -1.17  -1.72 
MDGL
Last Financial Announcement
31st of December 2020
NASDAQ
MDGL

Bicycle Therapeutics

17.30  0.28  1.65 
BCYC
Last Financial Announcement
31st of December 2020
NASDAQ
BCYC

BriaCell Therapeutics

5.00  0.13  2.67 
BCTX
Financial Report
5th of July 2022
NASDAQ
BCTX

Seres Therapeutics

3.57  0.16  4.69 
MCRB
Last Financial Announcement
31st of December 2020
NASDAQ
MCRB

Biocryst Pharma

9.10  0.07  0.78 
BCRX
Last Financial Announcement
31st of December 2020
NASDAQ
BCRX

Cel-Sci Corp

3.13  0.07  2.29 
CVM
Fiscal Year End
28th of December 2022
NYSEMKT
CVM

Cue Biopharma

3.30  -0.08  -2.37 
CUE
Last Financial Announcement
31st of December 2020
NASDAQ
CUE

Brainstorm Cell

2.89  -0.09  -3.02 
BCLI
Last Financial Announcement
31st of December 2020
NASDAQ
BCLI
NASDAQ
BCDA

Canopy Growth

5.52  -0.35  -5.96 
CGC
Financial Report
7th of June 2022
NASDAQ
CGC
NASDAQ
BCAB

Amicus Therapeutics

7.76  0.34  4.58 
FOLD
Last Financial Announcement
31st of December 2020
NASDAQ
FOLD

Moleculin Biotech

1.31  0.02  1.55 
MBRX
Last Financial Announcement
31st of December 2020
NASDAQ
MBRX

FSD Pharma

0.90  -0.02  -2.17 
HUGE
Fiscal Quarter End
31st of December 2021
NASDAQ
HUGE

Brooklyn Immunotherapeuti

0.72  -0.03  -4 
BTX
Last Financial Announcement
31st of December 2020
NYSEMKT
BTX

Microbot Medical

4.85  -0.17  -3.39 
MBOT
Last Financial Announcement
31st of December 2020
NASDAQ
MBOT

Bridgebio Pharma

7.61  0.22  2.98 
BBIO
Last Financial Announcement
31st of December 2020
NASDAQ
BBIO

Bristol-Myers Squibb

76.19  0.23  0.30 
BMY
Last Financial Announcement
31st of December 2020
NYSE
BMY

Mustang Bio

0.71  -0.01  -1.39 
MBIO
Last Financial Announcement
31st of December 2020
NASDAQ
MBIO

Bellus Health

8.25  -0.24  -2.83 
BLU
Last Financial Announcement
31st of December 2020
NASDAQ
BLU

Bausch Health

9.93  -0.22  -2.17 
BHC
Last Financial Announcement
31st of December 2020
NYSE
BHC

Brickell Biotech

0.16  -0.01  -5.88 
BBI
Last Financial Announcement
31st of December 2020
NASDAQ
BBI
This list of potential positions covers fama and french investing themes focus on testing asset pricing under different economic assumptions in USA. To view opportunities from different investing ideas or change the current investment horizon please use the panel above to switch your theme or use buttons below to analyze or optimize Pharmaceutical Products, or select one of many other different investing ideas from the investing ideas screen.
A typical investing theme composed of about 20 constituents, similar to a mutual fund or an ETF: these twenty equities are selected programmatically and evaluated daily using several Macroaxis equity rating mechanisms. The investor then can optimize these screened instruments to generate an optimal portfolio for a given investing idea or a nitch such as Pharmaceutical Products.